European Heart Journal Advance Access originally published online on December 8, 2007
European Heart Journal 2008 29(1):120-127; doi:10.1093/eurheartj/ehm567
Right coronary artery flow impairment in patients with pulmonary hypertension
1 Department of Pulmonary Diseases, Institute for Cardiovascular Research ICaR-VU, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, Noord-Holland, The Netherlands
2 Department of Physics and Medical Technology, Institute for Cardiovascular Research ICaR-VU, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, Noord-Holland, The Netherlands
3 Department of Physiology, Institute for Cardiovascular Research ICaR-VU, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, Noord-Holland, The Netherlands
4 Department of Clinical Epidemiology and Biostatistics, Institute for Cardiovascular Research ICaR-VU, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, Noord-Holland, The Netherlands
5 Department of Cardiology, Institute for Cardiovascular Research ICaR-VU, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, Noord-Holland, The Netherlands
6 Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
Received 26 July 2007; revised 31 October 2007; accepted 12 November 2007; online publish-ahead-of-print 8 December 2007.
* Corresponding author. Tel: +31 20 4444728, Fax: +31 20 4444382. Email: a.vonk{at}Vumc.nl
| Abstract |
|---|
|
|
|---|
Aims: This study investigates whether increased right ventricular (RV) pressure in pulmonary hypertension (PH) impairs right coronary artery (RCA) flow and RV perfusion.
Methods: In 25 subjects, five patients with idiopathic pulmonary arterial hypertension, nine patients with chronic thromboembolic pulmonary arterial hypertension, and 11 healthy controls, flow of the RCA and left anterior descending (LAD) artery was measured with MR flow quantification.
Results: In PH, RCA peak systolic and mean systolic flow were lower, 1.02 ± 0.62 mL/s and 0.42 ± 0.30 mL/s, than peak and mean diastolic flow, 2.99 ± 1.97 mL/s (P < 0.001) and 1.73 ± 0.97 mL/s (P < 0.001); a pattern similar to the LAD. In contrast, in controls, RCA peak and mean flow in systole, 1.63 ± 0.58 mL/s and 0.72 ± 0.23 mL/s, were comparable to peak and mean flow in diastole, 1.72 ± 0.48 mL/s and 0.93 ± 0.28 mL/s (NS).
The systolic-to-diastolic flow ratio in the RCA, and mean flow per gram RV tissue, were inversely related to RV mass, R = –0.61 (P = 0.009), and R = –0.73 (P < 0.001) and to RV pressure, R = –0.83 (P < 0.001), and R = –0.57 (P = 0.033).
Conclusion: Although in controls, RCA flow is similar in systole and diastole, in PH there is systolic flow impediment, which is proportional to RV pressure and mass. In patients with severe RV hypertrophy total mean flow is reduced.
Key Words: Coronary artery flow Pulmonary hypertension Right ventricle Magnetic resonance imaging Chronic thromboembolic pulmonary hypertension
| Introduction |
|---|
|
|
|---|
The right ventricle (RV) serves the pulmonary circulation. The RV is thin-walled with much less myocardial mass than the left ventricle (LV). In experiments in which the RV wall was damaged, no decrease in overall cardiac function was observed.1–3 As a result of these observations, a passive conduit function with minor circulatory function was allocated to the RV. However, in conditions of increased RV afterload, RV function becomes increasingly important. In 1936, Fineberg and Wiggers4 first postulated that circulatory failure following obstruction of the pulmonary circuit had no other cause than fatigue of the RV. Animal studies investigating RV function under stressed conditions found that RV function becomes increasingly important and that the ability of the RV to compensate is limited by RV perfusion, i.e. right coronary artery (RCA) flow.5–9
In patients with pulmonary hypertension (PH), the increased RV afterload causes RV hypertrophy which requires increased perfusion. Impairment of coronary flow might lead to cardiac dysfunction.10 Thus, a reduced right coronary flow might contribute importantly to RV failure in patients with PH. In a study of PH in dogs, it was found that RV pressure overload induces a reduction in RCA flow in systole.11,12 However, a reduced RCA flow in systole, possibly resulting in decreased perfusion per gram of cardiac tissue, has not been reported in patients with increased RV afterload due to PH.
The purpose of this study was to investigate the coronary artery flow pattern of the RCA in patients with PH in comparison with healthy controls and to investigate the influence of RV pressure and RV hypertrophy on the RCA flow.
| Methods |
|---|
|
|
|---|
Patients
Between March 2006 and September 2006, 48 patients were evaluated because of suspected PH. After initial evaluation, 30 patients were eligible for inclusion. Twenty patients underwent both a right heart catheterization and a cardiac MRI within 1–2 days and were included in the study. In three patients, it was not possible to obtain adequate measurements. Three study subjects, who were catheterized because of suspected PH, turned out to have normal pulmonary artery pressures and were included in the group of 11 healthy volunteers. The other healthy volunteers only had a cardiac MRI. The healthy volunteers were selected age and sex matched controls, without a history of coronary or cardiac disease, obtained from staff members of the Departments of Pulmonary Diseases and Physics and Medical Technology of the VU University Medical Center and from the Department of Cardiology of the Leiden University Medical Center and from their relatives. In total, 25 subjects were included in the study, five patients with idiopathic pulmonary arterial hypertension (IPAH), nine patients with chronic thromboembolic PH (CTEPH) and 11 healthy volunteers. The characteristics of the study subjects are summarized in Table 1. All patients had a mean pulmonary artery pressure >25 mmHg at right heart catheterization and a pulmonary capillary wedge pressure <15 mmHg. PH related to connective tissue disease, congenital heart disease, portal hypertension, HIV infection, or a hypoxic origin was excluded by further diagnostic work-up.13 Patients with CTEPH were diagnosed by pulmonary angiography. The institutional ethics review commission approved the study protocol and all patients gave informed consent. The study complies with the Declaration of Helsinki.
|
Right heart catheterization
Right heart catheterization was performed to obtain measurements of pulmonary artery pressure, RV pressure, right atrial pressure, pulmonary capillary wedge pressure, cardiac output, pulmonary vascular resistance, and mixed venous oxygen saturation. Cardiac output was determined using the Fick method. Oxygen consumption was measured during right heart catheterization. All patients had a vasodilatory test with inhaled nitric oxide (20 p.p.m.).
Cardiac magnetic resonance imaging
Cardiac MRI was performed with a 1.5T scanner (Sonata, Siemens Medical Solutions, Erlangen, Germany) with simultaneous ECG recording. Subjects were imaged in the supine position, using a circularly polarized phased array body coil attached to the chest.
Measurement of right and left ventricular mass and volume
Short-axis images of the heart from apex to base were acquired, covering the whole LV and RV. For the cine images, a gradient-echo pulse sequence (True-FISP by Siemens) was applied (repetition time/echo time, 34/1.6 ms; flip angle, 60°; field of view, 280 x 340 mm2; matrix, 150 x 256 pixels; pixel size, 1.9 x 1.3; slice thickness, 6 mm; slice distance, 4 mm). The endo- and epicardial contours of the RV and LV were delineated manually by a blinded observer and processed using MASS software (Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands) to obtain RV and LV masses and end-diastolic volumes.
Measurement of right coronary artery and left anterior descending flow
Coronary artery flow measurements were performed according to a previously described protocol, with minor modifications.14 In addition, MR contrast, (0.2 mmol/kg gadolinium-diethylene triamine pentaacetic acid) was used to enhance the angiographic images. First, localizing images using a pulse sequence (gradient echo, 11 ky lines per heartbeat, echo time 6.2 ms, repetition time 14 ms) were obtained to identify the origins of the RCA and left anterior descending (LAD). Then an oblique plane was obtained, showing a longitudinal section of the RCA and LAD (Figure 1). For the flow measurements, an image plane orthogonally to these longitudinal sections was positioned at 20 mm from the origin of the RCA and LAD. The flow in the coronary arteries was then determined in this image plane using a two-dimensional, spoiled gradient echo pulse sequence, and a one-dimensional velocity signal parallel to the flow in the coronary artery (velocity sensitivity, 40 cm/s; repetition time ms/echo time ms, 24/5; flip angle, 30°; field of view, 125 x 250 mm2; matrix 100 x 256 pixels; pixel size 1.16 x 0.98; slice thickness 6 mm). One fat saturation pulse was applied per cardiac cycle, directly after the R-wave trigger. Scan duration was maximal 960 ms, acquiring 40 frames. To prevent wrap-around artifacts, the posterior elements of the phased array coil were switched of and the field of view was positioned close to the anterior wall. Subtraction of velocity encoding phase maps was used to correct for inhomogeneity of the magnetic field, leaving only phase changes related to velocity. The velocity maps were analysed with the FLOW software (Department of Radiology, Leiden University Medical Center, Leiden). The magnitude image was used to select the position and size of the coronary artery cross-section. This area was selected as region of interest. The region of interest was repositioned manually in each temporal frame of the cardiac cycle. The area of the region of interest was kept constant during the cardiac cycle. Background motion was corrected by subtracting the velocity in the region of interest with the average velocity of a circular reference contour surrounding the coronary arteries with 3 pixel distance. If this reference contour incorporated a nearby blood vessel, it was manually corrected. The flow (mL/s) was calculated as the product of the coronary artery cross-sectional area and area averaged velocity. For each patient and control, a flow curve of the RCA and LAD flow was obtained (Figure 2). The R-wave on the electrocardiogram indicated the start of systole. The duration of systole was obtained from the contractile phase of short-axis cine images. The diastolic phase of the cardiac cycle was defined as the start of relaxation on the short-axis cine images until the next R-wave on the electrocardiogram. Peak systolic and diastolic flows were defined as the maximal flow measured during systole or diastole, respectively. Mean systolic flow was defined as the averaged flow during the systolic phase of the cardiac cycle. Mean diastolic flow was defined as the averaged flow during the diastolic phase of the cardiac cycle. Finally, the mean flow during one heartbeat was calculated by averaging the flow over the entire cardiac cycle. To average instantaneous flows over the groups, time was normalized by presenting it as percentage of heart period.
|
|
Statistical analysis
All data are expressed as mean ± SD. Comparisons between groups were made by the two-sided t-test, and chi-square test. To reduce Type I error due to multiple testing, P-values <0.03 were considered significant. To asses the difference in flow profiles in LAD and RCA between PH patients and the healthy controls, we used a multilevel analysis. This technique takes into account that the same subjects are repeatedly measured and it uses all the available data, irrespective of the number of repeated measurements. Furthermore, multilevel analysis is capable of dealing with variations in the duration of the cardiac cycle between patients.15 We used a random intercept model with as level 2 patient ID and as level 1 time. As independent variables, we used the dummy variable indicating the patient group and the interaction between the time during the cardiac cycle and patient group to see whether the effect of flow profile differed for patients with PH and healthy controls. We also considered non-linear effects of time by including the second and the third power of time in the model and its interaction with patient group. For each dependent variable, we choose the best fitting model based on the log-likelihood function. Pearson correlations were used to assess the relationship between coronary artery flow with RV and LV mass and pressures. The variables were normally distributed, or normalized with a log-transformation. In these analyses, P-values <0.05 were considered significant.
| Results |
|---|
|
|
|---|
The demographic, haemodynamic and morphometric characteristics of the study subjects are summarized in Table 1. Mean pulmonary artery pressure, pulmonary vascular resistance, RV mass, and RV volume were not different between the patients with IPAH and the patients with CTEPH. Systemic pressure did not differ between patients and controls. Mean pulmonary artery pressure of the patients with PH was 48 ± 15 mmHg and pulmonary vascular resistance was 600 ± 254 dyne s/cm5. RV mass in the PH patients was significantly increased compared to the RV mass of healthy controls, 107 ± 37 g vs. 61 ± 14 g (P < 0.001). The mean RVEDV in the PH patients, which was 174 ± 61 ml, was significantly increased compared to the mean RVEDV of healthy controls, which was 106 ± 34 ml (P < 0.001).
Coronary flow profiles
The flow profiles of the LAD and RCA, mean ± SD, with normalized time, are presented in Figure 3, and detailed information is given in Table 2. The coronary artery flow profiles in the LAD are similar in PH patients and control subjects. The flow profiles in the RCA of the PH patients show a biphasic flow profile, whereas this flow profile in control subjects is smooth and does not depend on contraction. In PH patients, RCA flow in systole is markedly reduced while diastolic flow is increased. We also compared the flow profiles between patients with PH and the healthy controls directly with a multilevel analysis. For RCA, a significant interaction effect was found between patient group and time. For patients with PH, the best model that fitted the RCA flow was a biphasic s-shaped curve, whereas for healthy patients a smoother profile was found (Figure 4). For LAD, there was no difference found between the flow profiles. The mean RCA flow over the entire cardiac cycle is increased in PH patients compared with healthy controls, 1.25 ± 0.69 mL/s compared with 0.86 ± 0.19 mL/s (P = 0.017).
|
|
|
The systolic-to-diastolic flow ratios are also reported in Table 2 and show that patients with PH have a significantly smaller mean systolic-to-diastolic flow ratio in the RCA compared with controls, 0.39 ± 0.28 compared with 0.82 ± 0.43 (P = 0.007). For the LAD, mean systolic-to-diastolic flow ratios were not different between PH patients and healthy controls.
Relation of coronary flow to ventricular pressure
The total mean flow in the RCA correlated with RV systolic pressure, R = 0.57 (P = 0.033). Total mean flow per gram myocardial tissue in the RCA also correlated with RV pressure, R =–0.57 (P = 0.033). In addition, mean diastolic flow in the RCA correlated with diastolic coronary perfusion pressure, defined as diastolic aortic pressure subtracted by end-diastolic ventricular pressure, R = 0.67 (P = 0.003). There was no significant correlation between the systolic coronary perfusion pressure and mean systolic flow in the RCA, R = 0.27 (P = 0.318). The contribution of RV pressure to the biphasic flow pattern in the RCA of patients with PH was investigated by correlating the systolic-to-diastolic flow ratio of the RCA to RV systolic pressure. There was a strong correlation between the mean RCA systolic-to-diastolic flow ratio and the RV systolic pressure, R = –0.83 (P < 0.001) (Figure 5).
|
Relation of coronary flow to ventricular mass
Total mean coronary flow in the RCA correlated with RV mass, R = 0.81 (P < 0.001). When we calculated mean systolic and diastolic coronary blood flow per gram myocardial mass, both PH patients and healthy controls have an average flow per mass of around 1 mL/min/g during diastole, in the LV as well as in the RV (Table 2). As expected, during systole, flow per mass was reduced in the LAD of both groups and in the RCA of patients with PH. The reduction of RCA flow during systole, expressed as the RCA systolic-to-diastolic flow ratio, correlated with RV mass, R = –0.61 (P = 0.009). Although the total mean coronary blood flow per gram myocardial tissue over the entire group combined was not significantly different in PH patients compared to controls, for both the RV and LV, we found that total coronary blood flow per gram myocardial mass declines in proportion to the amount of RV hypertrophy, R = –0.73 (P < 0.001) (Figure 6).
|
| Discussion |
|---|
|
|
|---|
We found that in patients with PH RCA flow becomes strongly biphasic with reduced flow in systole and higher flow in diastole. The phasic pattern starts to resemble the profile observed in the LAD. Our results also show that the reduction in systolic RCA flow is related to systolic RV pressure and to RV mass. In addition, we found that in patients with PH, the mean RCA flow per gram myocardial tissue over the entire group was similar to that of controls, but decreased in proportion to the extent of RV hypertrophy. It is thus expected that, especially in subendocardial layers, flow is insufficient in severe RV hypertrophy.
Animal studies have demonstrated a biphasic flow pattern in the left coronary artery but approximately equal systolic and diastolic right coronary artery flow.16 These observations have later been confirmed in human studies using the intracoronary Doppler guidewire17 and in non-invasive human studies using MR velocity measurements of the LAD and RCA.14
In animal models of RV stress, however, biphasic coronary flow profiles were observed in the RCA. This was seen in models of pulmonary embolism inducing acute RV stress,5–9 in models of congenital chronic RV stress,11,18 and in acquired chronic RV stress.12 In humans, little information is available about the effects of RV stress on RCA flow. Case studies of patients with congenital RV hypertension19 and patients with PH secondary to atrial septal defect20 report biphasic coronary flow profiles of the RCA and reversal of this pattern after cardial surgery, suggesting a relation between biphasic RCA flow and RV hypertension. One study by Akasaka et al.21 investigated the relation between RCA flow and PH in humans using intracoronary Doppler velocity measurements. Akasaka et al.21 studied 40 subjects, of which 17 patients had PH defined as a systolic pulmonary artery pressure >35 mmHg during right heart catheterization. The study included three patients with IPAH, nine patients with CTEPH, and five patients with PH secondary to connective tissue disease. They found a decreased systolic-to-diastolic flow ratio in the RCA of patients with PH and that the magnitude of this decrease in flow ratio was proportional to the coronary driving pressure. It was concluded that in the absence of differences in aortic pressure between patients with and without PH, the decreased systolic-to-diastolic flow ratio is attributed to increased RV pressure. This is in agreement with our data. Akasaka et al.21 found no differences in absolute systolic or diastolic RCA flow between patients with and without PH, which seems not in agreement with our present findings. However, their conclusion was based on flow measurements by means of Doppler in the proximal part of the RCA, which also includes flow to the right atrium and LV, since reliable measurement in a more distal RCA branch was only possible in 10 PH patients and nine controls of the 40 study subjects included in the study.
The main factors that determine systolic coronary flow impediment are RV pressure, muscle contractility, muscle thickening, and possible changes in the microcirculation. The RV pressure increase is the most obvious candidate here. Changes in the microcirculation were not studied but these changes are not expected to be large because mean flow (over the whole cardiac cycle) is not decreased.
In patients with severe PH, with reduced systemic pressure because of RV failure and decreased cardiac output, attempts to increase coronary driving pressure with phenylephrine have been unsuccesfull.23 Although RCA driving pressure increased with phenylephrine, RV performance and cardiac output decreased, possibly due to vasoconstriction.
Myocardial systolic compression also contributes to reduction of RCA flow. Systolic compression of myocardial fibers decreases the diameter of the myocardial microvascular bed and increases vascular resistance, even in an isobaric compression.22 In patients with PH, who have a RV, which is hypertrophied to withstand systolic pressures close to systemic pressures, this may be an important factor leading to a reduced RCA flow to the RV. In this study, the patients with PH had an increased RV mass and the reduction of RV perfusion was related to the extent of RV hypertrophy. This suggests that the RCA flow in patients with severe PH operates beyond the point of autoregulatory coronary flow reserve, despite the greater coronary flow reserve of the RV.24 Therefore, it is possible that PH patients with RV hypertrophy are more susceptible to subendocardial ischaemia similar to patients with LV hypertrophy. Indeed, Murray and Vatner25 have demonstrated that the subendocardial flow is reduced in dogs with RV hypertrophy and Gomez et al.10 reported the presence of RV ischaemia measured by myocardial scintigrapy in nine of 23 patients with PH. Further studies are necessary to evaluate to contribution of decreased RCA blood flow to RV dysfunction in patients with PH and to evaluate whether this decrease in RCA flow leads to RV ischaemia contributing to RV failure.
Study limitations
Measurements were performed in the RCA and LAD but not the circumflex coronary artery. Furthermore, there are anatomical variations in the RCA and LAD between individual patients, in some patients a small part of the perfusion of the LV is supplied by the RCA. However, it is unlikely that these anatomical variations explain the differences in right coronary flow between PH patients and healthy controls. Similarly, is it unlikely that this explains the decline in right coronary flow in proportion to RV mass in the PH patients.
| Conclusion |
|---|
|
|
|---|
Systolic RCA flow is impaired in PH. This reduction is proportional to RV mass and pressure.
Conflict of interest: none declared.
| Funding |
|---|
|
|
|---|
Institute for Cardiovascular Research ICaR-VU, VU University Medical Center.
| References |
|---|
|
|
|---|
- Starr I, Jeffers WA, Meade RH. The absence of conspicuous increments of venous pressure after severe damage to the right ventricle of the dog, with a discussion of the relation between clinical congestive failure and heart disease. Am Heart J (1943) 26:291.[CrossRef][Web of Science]
- Bakos ACP. The question of the function of the right ventricular myocardium: an experimental study. Circulation (1950) 1:724–732.
- Kagan A. Dynamic responses of the right ventricle following extensive damage by cauterization. Circulation (1952) 5:816–823.[Web of Science][Medline]
- Fineberg MH, Wiggers CJ. Compensation and failure of the right ventricle. Am Heart J (1936) 11:255.[CrossRef][Web of Science]
- Guyton AC, Lindsey AW, Gilluly JL. The limits of right ventricular compensation following acute increase in pulmonary circulatory resistance. Circ Res (1954) 2:326–332.
[Abstract/Free Full Text] - Salisbury PF. Coronary artery pressure and strength of right ventricular contraction. Circ Res (1955) 3:633–638.
[Abstract/Free Full Text] - Spotnitz HM, Berman MA, Epstein SE. Pathophysiology and experimental treatment of acute pulmonary embolism. Am Heart J (1971) 82:511–520.[CrossRef][Web of Science][Medline]
- Brooks H, Kirk ES, Vokonas PS, Urschel CW, Sonnenblick EH. Performance of the right ventricle under stress: relation to right coronary flow. J Clin Invest (1971) 50:2176–2183.[Web of Science][Medline]
- Klima UP, Guerrero JL, Vlahakes GJ. Myocardial perfusion and right ventricular function. Ann Thorac Cardiovasc Surg (1999) 5:74–80.[Medline]
- Gomez A, Bialostozky D, Zajarias A, Santos E, Palomar A, Martinez ML, Sandoval J. Right ventricular ischemia in patients with primary pulmonary hypertension. J Am Coll Cardiol (2001) 38:1137–1142.
[Abstract/Free Full Text] - Lowensohn HS, Khouri EM, Gregg DE, Pyle RL, Patterson RE. Phasic right coronary artery blood flow in conscious dogs with normal and elevated right ventricular pressures. Circ Res (1976) 39:760–766.
[Abstract/Free Full Text] - Murray PA, Baig H, Fishbein MC, Vatner SF. Effects of experimental right ventricular hypertrophy on myocardial blood flow in conscious dogs. J Clin Invest (1979) 64:421–427.[Web of Science][Medline]
- Galie N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, Olschewski H, Peacock A, Pietra G, Rubin LJ, Simonneau G, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie M, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, McGregor K, Morais J, Oto A, Smiseth OA, Barbera JA, Gibbs S, Hoeper M, Humbert M, Naeije R, Pepke-Zaba J, Task Force. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J (2004) 25:2243–2278.
[Free Full Text] - Marcus JT, Smeenk HG, Kuijer JP, Van der Geest RJ, Heethaar RM, Van Rossum AC. Flow profiles in the left anterior descending and the right coronary artery assessed by MR velocity quantification: effects of through-plane and in-plane motion of the heart. J Comput Assist Tomogr (1999) 23:567–576.[CrossRef][Web of Science][Medline]
- Twisk JWR. Applied Multilevel Analysis (2006) 2nd ed. Cambridge, UK: Cambridge university press.
- Gregg DE. Phasic blood flow and its determinants in the right coronary artery. Am J Physiol (1937) 580–588.
- Wilson RF, Laughlin DE, Ackell PH, Chilian WM, Holida MD, Hartley CJ. Transluminal, subselective measurement of coronary artery blood flow velocity and vasodilator reserve in man. Circulation (1985) 72:82–92.
[Abstract/Free Full Text] - Archie JP, Fixler DE, Ullyot DJ, Buckberg GD, Hoffman JIE. Regional myocardial blood flow in lambs with concentric right ventricular hypertrophy. Circ Res (1974) 34:143–154.
[Abstract/Free Full Text] - Divekar A, Auslender M, Colvin S, Artman M, Rutkowski M. Abnormal right coronary artery flow and multiple right ventricular myocardial infarctions associated with severe right ventricular systolic hypertension. J Am Soc Echocardiogr (2001) 14:70–72.[CrossRef][Web of Science][Medline]
- Ishibashi Y, Tanabe K, Oota T, Tanabu K, Sano K, Katou H, Murakami R, Shimada T, Morioka S. Phasic right coronary blood flow in a patient with right ventricular hypertension using transesophageal Doppler echocardiography. Cardiology (1995) 86:169–171.[Web of Science][Medline]
- Akasaka T, Yoshikawa J, Yoshida K, Hozumi T, Takagi T, Okura H. Comparison of relation of systolic flow of the right coronary artery to pulmonary artery pressure in patients with and without pulmonary hypertension. Am J Cardiol (1996) 78:240–244.[Web of Science][Medline]
- Westerhof N, Boer C, Lamberts RR, Sipkema P. Cross-talk between cardiac muscle and coronary vasculature. Physiol Rev (2006) 86:1263–1308.
[Abstract/Free Full Text] - Rich S, Gubin S, Hart K. The effects of phenylephrine on right ventricular performance in patients with pulmonary hypertension. Chest (1990) 98:1102–1106.[CrossRef][Web of Science][Medline]
- Bache RJ. Effects of hypertrophy on the coronary circulation. Prog Cardiovasc Dis (1988) 30:403–440.[CrossRef][Web of Science][Medline]
- Murray PA, Vatner SF. Reduction of maximal coronary vasodilator capacity in conscious dogs with severe right ventricular hypertrophy. Circ Res (1981) 48:25–33.
[Abstract/Free Full Text]
This article has been cited by other articles:
![]() |
H. J. Bogaard, K. Abe, A. Vonk Noordegraaf, and N. F. Voelkel The Right Ventricle Under Pressure: Cellular and Molecular Mechanisms of Right-Heart Failure in Pulmonary Hypertension Chest, March 1, 2009; 135(3): 794 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Kawut, N. Al-Naamani, C. Agerstrand, E. Berman Rosenzweig, C. Rowan, R. J. Barst, S. Bergmann, and E. M. Horn Determinants of Right Ventricular Ejection Fraction in Pulmonary Arterial Hypertension Chest, March 1, 2009; 135(3): 752 - 759. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






